Blockade of PDGF receptor signaling reduces myofibroblast number and attenuates renal fibrosis

Kidney International

Volumn 80, Issue 11, 2011, Pages 1119-1121

  Lebleu, Valerie S ^a   Kalluri, Raghu ^a,b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DESMIN; IMATINIB; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR D; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

CELL ACTIVATION; CELL ACTIVITY; CELL COUNT; CELL DIFFERENTIATION; CELL INFILTRATION; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FIBROBLAST; KIDNEY FIBROSIS; MACROPHAGE; MESENCHYME CELL; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RECEPTOR BLOCKING; RENAL PROTECTION; REVIEW; SIGNAL TRANSDUCTION; URETER OBSTRUCTION;

EID: 81155123597     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.300     Document Type: Note

References (14)

1. Chen Y-T, Chang F-C, Wu C-F et al. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 2011; 80: 1170-1181 .
2. Wang S, Wilkes MC, Leof EB et al. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis i n vivo. F ASEB J 2005; 19: 1-11. (Pubitemid 40069914)
3. Lassila M, Jandeleit-Dahm K, Seah KK et al. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice. J Am Soc Nephrol 2005; 16: 363-373. (Pubitemid 41725131)
4. Zeisberg EM, Potenta SE, Sugimoto H et al. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19: 2282-2287 .
5. Iwano M, Plieth D, Danoff TM et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350. (Pubitemid 34847966)
6. Humphreys BD, Lin SL, Kobayashi A et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85-97.
7. Diaz-Flores L, Gutierrez R, Madrid JF et al. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 2009; 24: 909-969.
8. Bergers G, Song S. The role of pericytes in bloodvessel formation and maintenance. Neuro Oncol 2005; 7: 452-464. (Pubitemid 41555617)
9. Ostman A, Heldin CH. PDGF receptors as targets in tumor treatment. Adv Cancer Res 2007; 97: 247-274 . (Pubitemid 46528991)
10. Ishii Y, Matsumoto Y, Watanabe R et al. Characterization of neuroprogenitor cells expressing the PDGF beta-receptor within the subventricular zone of postnatal mice. Mol Cell Neurosci 2008; 37: 507-518.
11. Betsholtz C. Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev 2004; 15: 215-228 . (Pubitemid 38781047)
12. Lindahl P, Johansson BR, Leveen P et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. S cience 1997; 277: 242-245. (Pubitemid 27446080)
13. Ronnov-Jessen L, Petersen OW. A function for filamentous alpha-smooth muscle actin: retardation of motility in fibroblasts. J Cell Biol 1996; 134: 67-80. (Pubitemid 26231521)
14. Lin SL, Kisseleva T, Brenner DA et al. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. A m J Pathol 2008; 173: 1617-1627.